Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours

Abstract Background Patients with metastatic small-intestinal neuroendocrine tumours (NET) have been shown to have a reduced quality of life compared to the general population and many have disabling symptoms during somatostatin analogue (SSA) treatment. The aim of this prospective study was to docu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Halfdan Sorbye, Liv Sylvi Meyer, Kjersti Elisabeth Mordal, Simen Myhre, Espen Thiis-Evensen
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-06-01
Colecção:Health and Quality of Life Outcomes
Assuntos:
Quality of life
Small-intestinal neuroendocrine tumour
Patient reported symptoms
Coping
Somatostatin analogue
Acesso em linha:http://link.springer.com/article/10.1186/s12955-020-01452-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados